- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Are Options Traders Betting on a Big Move in Alignment Healthcare Stock? | 1 | Zacks | ||
| ALIGNMENT HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| Do | Alignment Healthcare USA, LLC: Alignment Health Expands Access to Personalized Senior Care in 2027 with New Markets, Provider Networks and Medicare Advantage Plan Options | 1 | GlobeNewswire (USA) | ||
| 16.09. | Alignment Healthcare extends retreat, falls an additional 16% | 21 | Seeking Alpha | ||
| 16.09. | TD Cowen reiterates Alignment Healthcare stock Buy rating amid Q3 headwinds | 18 | Investing.com | ||
| 10.09. | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | 1 | GlobeNewswire (USA) | ||
| 09.09. | Kaplan Fox Encourages Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) to Contact the Firm Regarding Potential Securities Law Violations | 1 | Barchart.com | ||
| 08.09. | Alignment Healthcare USA, LLC: Alignment Health Plan and Hoag Health System Increase Access to Award-Winning Care for Orange County Seniors | 3 | GlobeNewswire (USA) | ||
| 18.08. | Alignment Healthcare files motion to dismiss whistleblower lawsuit | 16 | Seeking Alpha | ||
| 07.08. | Can ALHC's Raised 2026 Outlook Offset Heavier Second-Half Spending? | 16 | Zacks | ||
| 03.08. | Sorgen um Gewinnentwicklung: Raymond James stuft Alignment Healthcare ab | 2 | Investing.com Deutsch | ||
| 03.08. | Raymond James downgrades Alignment Healthcare stock rating on earnings visibility concerns | 2 | Investing.com | ||
| 31.07. | Alignment Healthcare boasts 32% revenue jump in Q2, lifts 2026 outlook | 1 | FierceHealthcare | ||
| 31.07. | Alignment Healthcare forecasts $5.20B-$5.23B 2026 revenue while raising membership outlook to 298k-301k | 8 | Seeking Alpha | ||
| 30.07. | Alignment Healthcare, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 30.07. | Alignment Healthcare Turns Profit As Insurer Gets Handle On Costs | 1 | Forbes | ||
| 30.07. | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | 970 | GlobeNewswire (Europe) | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| 30.07. | Alignment Healthcare, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.07. | Reasons to Retain Alignment Healthcare Stock in Your Portfolio for Now | 1 | Zacks | ||
| 10.07. | Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | 1.167 | Newsfile | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen | |
| 09.07. | Former exec alleges Alignment Healthcare leaders juiced profits to boost bonuses | 1 | FierceHealthcare |
1 2 3 Weiter >>
51 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 4,889 | -0,20 % | Teladoc Aktie setzt Talfahrt fort: Chefjurist geht, Sorgen bleiben | ||
| HIMS & HERS HEALTH | 25,700 | -0,23 % | Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership | Kultar Garcha, MD, joins as Chief Medical Officer of the UK and EMEA, and Matt Vickers, FRACGP, MBBS, BMedSci, AICGG, is named Chief Medical Officer of Hims Australia, guiding clinical strategy... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,070 | +3,87 % | Sernova Biotherapeutics Inc ÜBERRASCHT Anleger: Ist der Kurssprung um 33,2 % erst der Anfang? - Jetzt lesen! | ||
| CERENOME | 1,484 | -4,99 % | Cerenome, Inc.: Cerenome Expects $1.55 Million in CNSide Third Quarter Gross Billings | Lead test on track for 200 million covered lives and beneficiaries by early 2027 after CMS meeting On track to launch expanded CNSide testing menu with multiple tests in Q4 2026 HOUSTON, Sept. 30... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,960 | -6,67 % | Atossa plans shareholder stake in potential PRV proceeds | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| TANDEM DIABETES | 14,800 | +0,68 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,075 | -0,46 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| QUIDELORTHO | 9,624 | +0,65 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,525 | +0,60 % | Veru Inc.: Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines' RASONQUE) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial | ||
| LIFEWARD | 5,850 | -1,85 % | Lifeward Ltd. - 8-K, Current Report | ||
| CLOVER HEALTH INVESTMENTS | 3,720 | -4,62 % | Clover Health adds two directors to board | ||
| SENSEONICS | 8,800 | 0,00 % | TD Cowen bestätigt Kaufempfehlung für Senseonics Aktie aufgrund von Wachstumstreibern | ||
| TEMPEST THERAPEUTICS | 0,799 | -1,57 % | Tempest Therapeutics beruft Nancy Freda-Smith in den Verwaltungsrat | ||
| NANO-X IMAGING | 0,633 | -0,50 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer |
ALIGNMENT HEALTHCARE INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 7,945 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ALIGNMENT HEALTHCARE INC finden Sie auf Wallstreet Online.